Patents by Inventor Munehiro Noda

Munehiro Noda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220226944
    Abstract: A method for manufacturing a sintered gear comprising the steps of: preparing a cylindrical green compact; gear-cutting the green compact with a hob; and sintering the gear-hobbed green compact, wherein the hob is such that a ratio of a number of cutting edges thereof per round to a number of starts thereof exceeds 8.
    Type: Application
    Filed: April 28, 2020
    Publication date: July 21, 2022
    Applicants: Sumitomo Electric Industries, Ltd., Sumitomo Electric Sintered Alloy, Ltd.
    Inventors: Kazunari SHIMAUCHI, Tomoyuki UENO, Tomoyuki ISHIMINE, Munehiro NODA
  • Publication number: 20220152701
    Abstract: A method of making a sintered body includes a step of preparing raw material powder containing powder of inorganic material, a step of producing a powder compact having a high-density portion with a relative density of 93% or more and a low-density portion with a relative density of less than 93% by compressing the raw material powder injected into a mold, a step of producing a machined compacted part by machining at least the high-density portion of the powder compact, and a step of sintering the machined compacted part to make a sintered body, wherein a perimeter shape of a cavity constituted by the mold in a cross-section perpendicular to an axial direction of the mold is such than a maximum stress applied to an inner perimeter surface of the mold during a compacting process using the mold is less than or equal to 2.
    Type: Application
    Filed: April 13, 2020
    Publication date: May 19, 2022
    Applicants: SUMITOMO ELECTRIC INDUSTRIES, LTD., SUMITOMO ELECTRIC SINTERED ALLOY, LTD.
    Inventors: Tomoyuki ISHIMINE, Shigeki EGASHIRA, Munehiro NODA, Takayuki TASHIRO, Kazunari SHIMAUCHI
  • Publication number: 20210162499
    Abstract: A method for manufacturing a sintered member includes a step of preparing a raw material powder containing an iron-based powder; a step of forming a green compact having a relative density of 97% or more and having a solid cylindrical shape or hollow cylindrical shape by compacting the raw material powder; and a step of sintering the green compact. The raw material powder contains at least one of a mixed powder containing pure iron powder and Ni powder and an iron alloy powder containing Ni as an additive element. The total amount of the Ni powder and Ni serving as the additive element in the raw material powder is 1 mass % or more.
    Type: Application
    Filed: May 8, 2018
    Publication date: June 3, 2021
    Inventors: Tomoyuki ISHIMINE, Shigeki EGASHIRA, Munehiro NODA
  • Publication number: 20200208244
    Abstract: A sintered material made of an iron-based alloy is provided, wherein a content of Ni is more than 0.2 mass % and 10 mass % or less in an entire iron-based alloy; a content of C is more than 0 mass % and 2.0 mass % or less in the entire iron-based alloy; at least one element selected from Mo, Mn, Cr B and Si is more than 0 mass % and 5.0 mass % or less in total in the entire iron-based alloy; and a rest of the iron-based alloy is Fe and incidental impurities. A content of Ni in a local region of the iron-based alloy is more than 0.2 mass % and less than 21 mass %. A relative density is 97% or more.
    Type: Application
    Filed: July 19, 2018
    Publication date: July 2, 2020
    Inventors: Shigeki EGASHIRA, Tomoyuki ISHIMINE, Munehiro NODA, Takashi SEKIYA
  • Patent number: 8445649
    Abstract: An antibody provided by the present invention has a low reactivity with amyloid precursor proteins, and has a higher reactivity with amylospheroids than with amyloid ? fibrils or monomeric amyloid ?-proteins. According to the present invention, an antibody is provided that has a higher reactivity with amylospheroids than with amyloid precursor proteins, and has any one or more of the following properties: (i) a higher activity with amylospheroids than with amyloid ? fibrils; (ii) a higher reactivity with amylospheroids than with monomeric amyloid ?-proteins; and (iii) an activity of inhibiting neuronal cell death induced by amylospheroids.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: May 21, 2013
    Assignee: Tao Health Life Pharma Co., Ltd.
    Inventors: Minako Hoshi, Michio Sato, Shoji Ideno, Koji Naito, Satoshi Horie, Munehiro Noda, Hajime Horii
  • Publication number: 20100297662
    Abstract: An antibody provided by the present invention has a low reactivity with amyloid precursor proteins, and has a higher reactivity with amylospheroids than with amyloid ? fibrils or monomeric amyloid ?-proteins. According to the present invention, an antibody is provided that has a higher reactivity with amylospheroids than with amyloid precursor proteins, and has any one or more of the following properties: (i) a higher activity with amylospheroids than with amyloid ? fibrils; (ii) a higher reactivity with amylospheroids than with monomeric amyloid ?-proteins; and (iii) an activity of inhibiting neuronal cell death induced by amylospheroids.
    Type: Application
    Filed: October 29, 2008
    Publication date: November 25, 2010
    Inventors: Minako Hoshi, Michio Sato, Shoji Ideno, Koji Naito, Satoshi Horie, Munehiro Noda, Hajime Horii
  • Patent number: 7084331
    Abstract: The present invention provides a rice plant that shows enhanced growth and increased seed production, which also enables reduction of the use of chemical fertilizers. In the present invention, a nitrogen-fixing endophytic bacterium is isolated from bacteria symbiotically inhabiting natural plants, the isolated endophytic bacterium is artificially proliferated and then artificially inoculated into rice plants, and thus, the nitrogen-fixing endophytic bacteria are allowed to infect to rice plants.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: August 1, 2006
    Assignees: Mayekawa Mfg. Co., Ltd.
    Inventors: Tsuyoshi Isawa, Naoya Hiruma, Takahiro Imada, Munehiro Noda, Yohsuke Kurihara, Madoka Kon
  • Patent number: 7037879
    Abstract: The objective of the present invention is to confer pest resistance to plants of Poaceae without using any chemically synthesized pesticides. The pest resistance can be conferred to plants of Poaceae by isolating from a natural plant an endophytic bacterium capable of expressing pest resistance, artificially culturing the endophytic bacterium, and introducing the bacteria to a Poaceae plant of interest.
    Type: Grant
    Filed: May 2, 2002
    Date of Patent: May 2, 2006
    Assignee: Society for Techno-Innovation of Agriculture Forestry Fisheria and Mayekawa Mfg. Co., Ltd.
    Inventors: Takahiro Imada, Naoya Hiruma, Tsuyoshi Isawa, Munehiro Noda, Yohsuke Kurihara, Madoka Kon
  • Publication number: 20030195117
    Abstract: The objective of the present invention is to confer pest resistance to plants of Poaceae without using any chemically synthesized pesticides.
    Type: Application
    Filed: May 2, 2002
    Publication date: October 16, 2003
    Inventors: Takahiro Imada, Naoya Hiruma, Tsuyoshi Isawa, Munehiro Noda, Yohsuke Kurihara, Madoka Kon
  • Patent number: 6617133
    Abstract: The invention provides a process for purifying recombinant human serum albumin (rHSA) by heating a-culture medium containing rHSA and the rHSA-producing host cells, feeding said heated solution upwardly into a fluidized bed in which adsorbent particles are suspended to effect contacting with the adsorbent particles and then recovering the adsorbed fraction containing the rHSA, and a composition comprising rHSA which shows a A350/A280 ratio of below 0.015, when formulated into a 25% solution of said albumin.
    Type: Grant
    Filed: May 24, 1999
    Date of Patent: September 9, 2003
    Assignee: Mitsubishi Pharma Corporation
    Inventors: Munehiro Noda, Akinori Sumi, Takao Ohmura, Kazumasa Yokoyama
  • Publication number: 20030135898
    Abstract: [Problems to be Solved]
    Type: Application
    Filed: May 2, 2002
    Publication date: July 17, 2003
    Inventors: Tsuyoshi Isawa, Naoya Hiruma, Takahiro Imada, Munehiro Noda, Yohsuke Kurihara, Madoka Kon
  • Patent number: 5986062
    Abstract: Human serum albumin obtained by gene manipulation techniques can be purified by a combination of specified steps in which a culture supernatant obtained from a human serum albumin-producing host is subjected to ultrafiltration, heat treatment, acid treatment and another ultrafiltration, followed by subsequent treatments with a cation exchanger, a hydrophobic chromatography carrier and an anion exchanger, and by salting-out to thereby obtain a pure form of human serum albumin which contains substantially no proteinous and polysaccharide contaminants, which is formulated into a pharmaceutical preparation. The thus obtained human serum albumin can further be purified by treating recombinant human serum albumin with a hydrophobic chromatography carrier at pH of 2 to 5 and a salt concentration of 0.4 to 1 and exposing the carrier to a pH of 6 to 8 and a salt concentration of 0.01 to 0.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: November 16, 1999
    Assignee: The Green Cross Corporation
    Inventors: Takao Ohmura, Akinori Sumi, Wataru Ohtani, Naoto Furuhata, Kazuya Takeshima, Kaeko Kamide, Munehiro Noda, Masahide Kondo, Syoichi Ishikawa, Kazuhiro Oohara, Kazumasa Yokoyama, Nagatoshi Fujiwara
  • Patent number: 5962649
    Abstract: The invention provides a process for purifying recombinant human serum albumin (rHSA) by heating a culture medium containing rHSA and the rHSA-producing host cello, feeding said heated solution upwardly into a fluidized bed in which adsorbent particles are suspended to effect contacting with the adsorbent particles and then recovering the adsorbed fraction containing the rHSA, and a composition comprising rHSA which shows a A35D/A280 ratio of below 0.015, when formulated into a 25% solution of said albumin.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: October 5, 1999
    Assignee: Yoshitomo Pharmaceutical Industries, Ltd.
    Inventors: Munehiro Noda, Akinori Sumi, Takao Ohmura, Kazumasa Yokoyama
  • Patent number: 5710253
    Abstract: A method for decoloring a recombinant human serum albumin by treating the albumin with a reducing agent is disclosed. Also, a method for decoloring a recombinant human serum albumin by treating the albumin with a method removing free polysaccharides with a cation exchanger followed by heat treatment is disclosed. The present invention provides a recombinant human serum albumin, coloring of which is fully suppressed by preventing binding of certain coloring components, which are contained in the raw materials or contaminants secreted by a microorganism, to human serum albumin so as not to cause coloring of the human serum albumin.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: January 20, 1998
    Assignee: The Green Cross Corporation
    Inventors: Wataru Ohtani, Naoto Furuhata, Akinori Sumi, Munehiro Noda, Takao Ohmura
  • Patent number: 5521287
    Abstract: Human serum albumin obtained by gene manipulation techniques can be purified by a combination of specified steps in which a culture supernatant obtained from a human serum albumin-producing host is subjected to ultrafiltration, heat treatment, acid treatment and another ultrafiltration, followed by subsequent treatments with a cation exchanger, a hydrophobic chromatography carrier and an anion exchanger, and by salting-out to thereby obtain a pure form of human serum albumin which contains substantially no proteinous and polysaccharide contaminants, which is formulated into a pharmaceutical preparation. The thus obtained human serum albumin can further be purified by treating recombinant human serum albumin with a hydrophobic chromatography carrier at pH of 2 to 5 and a salt concentration of 0.4 to 1 and exposing the carrier to a pH of 6 to 8 and a salt concentration of 0.01 to 0.
    Type: Grant
    Filed: February 25, 1994
    Date of Patent: May 28, 1996
    Assignee: The Green Cross Corporation
    Inventors: Takao Ohmura, Akinori Sumi, Wataru Ohtani, Naoto Furuhata, Kazuya Takeshima, Kaeko Kamide, Munehiro Noda, Masahide Kondo, Syoichi Ishikawa, Kazuhiro Oohara, Kazumasa Yokoyama, Nagatoshi Fujiwara
  • Patent number: 5440018
    Abstract: Human serum albumin obtained by gene manipulation techniques can be purified by a combination of specified steps in which a culture supernatant obtained from a human serum albumin-producing host is subjected to ultrafiltration, heat treatment, acid treatment and another ultrafiltration, followed by subsequent treatments with a cation exchanger, a hydrophobic chromatography carrier and an anion exchanger, and by salting-out to thereby obtain a pure form of human serum albumin which contains substantially no proteinous and polysaccharide contaminants, which is formulated into a pharmaceutical preparation. This process makes it possible to effeciently purify recombinant human serum albumin and to provide substantially pure human serum albumin which does not contain producer host-related substances and other contaminants and is sufficiently free from coloration.
    Type: Grant
    Filed: March 24, 1993
    Date of Patent: August 8, 1995
    Assignee: The Green Cross Corporation
    Inventors: Takao Ohmura, Akinori Sumi, Wataru Ohtani, Naoto Fuluhata, Kazuya Takeshima, Kaeko Kamide, Munehiro Noda, Masahide Kondo, Syoichi Ishikawa, Kazuhiro Oohara, Kazumasa Yokoyama
  • Patent number: 5219995
    Abstract: The present invention describes a process for activating Factor II to Factor II.sub.a by incubating Factor II in the presence of Factor V, Factor X.sub.a, phospholipids, and calcium ions. Each of the factors is prepared from a single impure protein fraction which includes Factors II, V and X. The Factor II, V and X purification procedure comprises the steps of DEAE ligand chromatography and precipitation by the addition of barium chloride. Factor V is recovered from the barium chloride supernatant, and Factors II and X are contained in the barium chloride precipitate. The barium chloride precipitate is dissolved in an aqueous solution and is applied to a chromatographic resin coupled with a ligand which binds Factor X and Factor II weakly or not at all. Factor II is recovered from the fraction, which remains unbound or weakly bound to the Factor X binding ligand. Factor X.sub.
    Type: Grant
    Filed: July 14, 1992
    Date of Patent: June 15, 1993
    Assignee: Alpha Therapeutic Corporation
    Inventors: Steven W. Herring, Yahiro Uemura, Munehiro Noda, Kenneth T. Shitanishi
  • Patent number: PP11428
    Abstract: The present invention relates to a variety obtained by selecting and cross-breeding those individuals producing the insect resistance substance peramine from Glyceria ischyroneura Steud. growing wild in various districts of Japan.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: June 27, 2000
    Assignee: Shibaura Institute of Technology
    Inventors: Satoshi Shinozaki, Hiroyuki Sano, Naoya Hiruma, Takahiro Imada, Munehiro Noda, Fumiyoshi Akaike, Sachiko Yamashima, Madoka Kon